AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Operating margin (%)

Immuno-Biological Laboratories Co., Ltd.【JP:4570】

Market cap
¥15.7B
P/E ratio
59.3x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndOperating margin (%) YoY (%)
Mar 31, 202521.6+69.08%
Mar 31, 202412.8+73.85%
Mar 31, 20237.3-138.92%
Mar 31, 2022-18.9-52.79%
Mar 31, 2021-40-61.27%
Mar 31, 2020-103.2+364.36%
Mar 31, 2019-22.2+245.52%
Mar 31, 2018-6.4-95.88%
Mar 31, 2017-156+1385.94%
Mar 31, 2016-10.5-57.83%
Mar 31, 2015-24.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)